Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-09 07:17 • The Motley Fool Mixed Axe Cap view: Selective

Coca-Cola stock needs to climb about 14% from $88 to reach $100 by end of 2027. The article argues this is achievable if earnings grow at recent rates (~8% annually), supported by improving volume growth (up to 5% in latest quarter) and stable pricing power. However, the prediction relies on sustained earnings growth and assumes current valuation multiples hold, with risks if volume growth slows.

Axe note: Coca-Cola’s steady earnings and improving volumes support its climb to $100, but risk lies in sustaining this momentum.

2026-10-09 02:15 • The Motley Fool Positive Axe Cap view: Selective

UBS analyst Michael Yee labeled Novo Nordisk a value trap, favoring Eli Lilly's growth prospects in the GLP-1 drug market. However, the article argues that while Eli Lilly currently leads, Novo Nordisk's strong R&D capabilities and 4.7% dividend yield make it a potential long-term turnaround story for patient investors willing to wait 5-10 years for recovery.

Axe note: While UBS warns against Novo Nordisk’s near-term challenges, its solid dividend and R&D could pay off down the line.

2026-10-09 01:13 • The Motley Fool Positive Axe Cap view: Selective

Nebius Group and SoundHound AI represent different plays in the AI infrastructure boom. Nebius operates a specialized cloud platform for AI workloads with 350% revenue growth and demand exceeding supply, while SoundHound AI provides voice-enabled software with 99% revenue growth but faces profitability challenges and integration risks. The author recommends Nebius due to its stronger market position and less competitive landscape.

Axe note: Nebius Group’s AI cloud infrastructure growth looks stronger and more durable than SoundHound AI’s voice software struggles.